drugset / Trial / NCT02645890

Study to Compare the Safety and Pharmacokinetics of CKD-397

NCT02645890

Phase 1 Completed 36 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and pharmacokinetics profiles of CKD-397 in healthy male volunteers.

Timeline

Start
2015-11
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule Oral
Comparator Tamsulosin Other / unclassified Oral